Provided by Tiger Trade Technology Pte. Ltd.

Zura Bio

5.93
-0.1100-1.82%
Post-market: 5.930.00000.00%19:58 EDT
Volume:703.63K
Turnover:4.17M
Market Cap:562.64M
PE:-5.59
High:6.14
Open:6.04
Low:5.76
Close:6.04
52wk High:7.44
52wk Low:0.9700
Shares:94.88M
Float Shares:49.74M
Volume Ratio:1.00
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0600
EPS(LYR):-1.0600
ROE:-52.49%
ROA:-32.05%
PB:5.54
PE(LYR):-5.59

Loading ...

Zura Bio Announces Closing of Its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

THOMSON REUTERS
·
Feb 27

Zura Bio Files Amended 8-K to Update Legal Opinion and Consent Exhibits

Reuters
·
Feb 26

Zura Bio Ltd - Enters Underwriting Agreement With Leerink, Piper Sandler, Cantor - SEC Filing

THOMSON REUTERS
·
Feb 26

Zura Bio Ltd - Net Proceeds From Offering Expected to Be $134.6 Mln - SEC Filing

THOMSON REUTERS
·
Feb 26

Zura Bio 18.2M share Spot Secondary priced at $6.25

TIPRANKS
·
Feb 25

BRIEF-Zura Bio Announces Pricing Of $125 Million Public Offering Of Class A Ordinary Shares And Pre-Funded Warrants

Reuters
·
Feb 25

Zura Bio Ltd. Director Mark Eisner Files Initial Statement of Beneficial Ownership (Form 3)

Reuters
·
Feb 25

Zura Bio announces common stock offering, amount not stated

TIPRANKS
·
Feb 25

BUZZ-Zura Bio falls after commencing stock offering

Reuters
·
Feb 25

Zura Bio Announces Proposed Public Offering of Class a Ordinary Shares and Pre-Funded Warrants

THOMSON REUTERS
·
Feb 25

Zura Bio Strengthens Board with Immunology and R&D Leaders

TIPRANKS
·
Feb 23

BRIEF-Zura Bio Welcomes Accomplished Drug Development Leaders To Board Of Directors

Reuters
·
Feb 23

Zura Bio Appoints Mark Eisner and Ajay Nirula to Board as Neil Graham Steps Down

Reuters
·
Feb 23

Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.d., M.p.h., and Ajay Nirula, M.d., Ph.d., to Board of Directors

THOMSON REUTERS
·
Feb 23

Zura Bio Initiated at Outperform by Wedbush

Dow Jones
·
Feb 09

Wedbush Initiates Zura Bio at Outperform With $15 Price Target

MT Newswires Live
·
Feb 09

Zura Bio initiated with an Outperform at Wedbush

TIPRANKS
·
Feb 09

Zura Bio nimmt am Guggenheim Emerging Outlook: Biotech Summit in New York teil

Reuters
·
Feb 04

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jan 31

Zura Bio Ltd. Files Initial Statement of Beneficial Ownership for Director Parvinder Thiara

Reuters
·
Jan 28